Merck Q1 sales beat

Merck beats quarterly sales expectations as Keytruda fuels growth

Merck beat Q1 sales expectations with Keytruda revenue rising 12% to $8 billion, offsetting acquisition charges that caused a net loss. The company raised its full-year profit guidance as investors fo